Article info
Therapeutics
Systematic review and meta-analysis
Cholinesterase inhibitors should not be prescribed for mild cognitive impairment
- Correspondence to : Dr Tom C Russ, Division of Psychiatry, Kennedy Tower, Royal Edinburgh Hospital, University of Edinburgh, Morningside Terrace, Edinburgh EH10 5HF, UK; tom.russ{at}nhs.net
Citation
Cholinesterase inhibitors should not be prescribed for mild cognitive impairment
Publication history
- First published January 30, 2014.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions